feed,title,long_url,short_url
Benzinga,"Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine",https://www.benzinga.com/pressreleases/20/09/n17483045/valneva-and-dynavax-announce-commercial-supply-agreement-for-inactivated-adjuvanted-covid-19-vacci,https://j.mp/3isbBVL
Benzinga,FDA grants DupixentÂ® (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis,https://www.benzinga.com/pressreleases/20/09/g17483041/fda-grants-dupixent-dupilumab-breakthrough-therapy-designation-for-eosinophilic-esophagitis,https://j.mp/2RnxpG1
Benzinga,Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government,https://www.benzinga.com/pressreleases/20/09/g17483040/valneva-announces-major-covid-19-vaccine-partnership-with-u-k-government,https://j.mp/3bVgm7w
Benzinga,Kiadis announces U.S. FDA approval of the Abigail Wexner Research Institute at Nationwide Children's Hospital's IND for a COVID-19 clinical trial with off-the-shelf K-NK cells using Kiadis' proprietary platforms,https://www.benzinga.com/pressreleases/20/09/g17483038/kiadis-announces-u-s-fda-approval-of-the-abigail-wexner-research-institute-at-nationwide-childrens,https://j.mp/3c2kjYf
